Esperance Pharmaceuticals Competitors and Similar CompaniesClear all
Esperance Pharmaceuticals's competitors and similar companies include VITRUVIAN BioMedical, ImmuneSensor Therapeutics, Curtana Pharmaceuticals and Ohm Oncology.
 Esperance Pharmaceuticals Esperance Pharmaceuticals is a company developing a class of targeted anticancer drugs. |  VITRUVIAN BioMedical VITRUVIAN BioMedical is a biotechnology company engaged in the development and commercialization of diagnostics and therapeutics with an initial focus on Alzheimer's Disease. |  ImmuneSensor Therapeutics ImmuneSensor Therapeutics is a company aiming to treat cancer and autoimmune diseases. |  Curtana Pharmaceuticals Curtana Pharmaceuticals is a company specializing in therapies for brain cancer. |  Ohm Oncology Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds. | |
Founding Date | Founding Date 2006 | Founding Date 2010 | Founding Date 2014 | Founding Date 2013 | Founding Date 2015 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Houston, US HQ | Locations Addison, US HQ | Locations Dallas, US HQ | Locations Austin, US HQ | Locations Austin, US HQ |
Employees | Employees 8 | Employees 6 | Employees 11 | Employees 7 | Employees 167% decrease |
For sources of this data, please see the company profile
View Company Profiles
VITRUVIAN BioMedical
HQ
Addison, US
Employees
6
VITRUVIAN BioMedical is a biotechnology company engaged in the development and commercialization of diagnostics and therapeutics with an initial focus on Alzheimer's Disease.
View companyImmuneSensor Therapeutics
HQ
Dallas, US
Employees
11
ImmuneSensor Therapeutics is a company aiming to treat cancer and autoimmune diseases.
View companyCurtana Pharmaceuticals
HQ
Austin, US
Employees
7
Curtana Pharmaceuticals is a company specializing in therapies for brain cancer.
View companyOhm Oncology
HQ
Austin, US
Employees
1
Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds.
View company